The Efficacy and Tolerability of ABVD and Stanford V in Older Hodgkin Lymphoma Patients: A Comprehensive Analysis from the North American Intergroup Trial E2496

There is a lack of contemporary prospective data examining the ABVD (adriamycin, bleomycin, vinblastine, dacarbazine) and Stanford V (SV; doxorubicin, vinblastine, mechlorethamine, vincristine, bleomycin, etoposide, prednisone) regimens in older Hodgkin lymphoma (HL) patients. Forty-four advanced-st...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Evens, Andrew M., Hong, Fangxin, Gordon, Leo I., Fisher, Richard I., Bartlett, Nancy L., Connors, Joseph M., Gascoyne, Randy D., Wagner, Henry, Gospodarowicz, Mary, Cheson, Bruce D., Stiff, Patrick J., Advani, Ranjana, Miller, Thomas P., Hoppe, Richard T., Kahl, Brad S., Horning, Sandra J.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2013
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3906856/
https://ncbi.nlm.nih.gov/pubmed/23356491
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bjh.12222
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares